secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2025-04-30T23:59:59+00:00
Accession:  0001641172-25-007852
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspire Biopharma settles lender default claims, extends note maturities by 75 days
--------------------------------------------------------------------------------

- Lenders withdrew April 1 and April 9 default/acceleration notices; defaults deemed cured with no admission of fault.
- Maturities extended: Dec 13 note to Aug 15, 2025; Sep/Oct 2024 notes to Sep 10, 2025.
- Company to issue 625,000 shares to Blackstone and file S-1 registration by May 13, 2025.
- Lock-ups removed for Cobra, Blackstone, Thor; new leak-out restrictions based on trading volume through Aug 20, 2025.
- Lenders waived additional interest/penalties; company to pay up to $60,000 in deal costs added to principal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000164117225007852/0001641172-25-007852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000164117225007852/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-007852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer